insulin glargine
insulin glargine is listed in the FDA National Drug Code directory with 12 NDC codes, marketed under brand names including Lantus, Insulin glargine U-300 Max, LANTUS SOLOSTAR. Available dosage form: injection, solution.
Drug Details
- Generic Name
- insulin glargine
- Brand Names
- Lantus, Insulin glargine U-300 Max, LANTUS SOLOSTAR, TOUJEO, Insulin Glargine Solostar, Insulin glargine U-300, Lantus Solostar, TOUJEO Max
- Application Number
- BLA021081
- Sponsor
- A-S Medication Solutions
- NDC Codes
- 12
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- INSULIN GLARGINE
Indications and Usage
1 INDICATIONS AND USAGE LANTUS is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. LANTUS is a long-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ( 1 ) Limitations of Use Not recommended for the treatment of diabetic ketoacidosis. ( 1 ) Limitations of Use LANTUS is not recommended for the treatment of diabetic ketoacidosis.